ORBIMED ADVISORS LLC – Gilead Sciences, Inc. Transaction History
ORBIMED ADVISORS LLC portfolio value:
$0
portfolio value
ORBIMED ADVISORS LLC quarter portfolio value change:
-0.19%
quarter
Gilead Sciences, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Decrease | -100.00% | -287.6K shares | -17.77M | $61.69 | 0 |
| Q2 2022 | share | 0.00% | 0 shares | 679K | $61.81 | 287.6K | |
| Q1 2022 | share | 0.00% | 0 shares | -3.78M | $59.45 | 287.6K | |
| Q4 2021 | share | 0.00% | 0 shares | 794K | $73.36 | 287.6K | |
| Q3 2021 | share | 0.00% | 0 shares | 285K | $69.85 | 287.6K | |
| Q2 2021 | share | 0.00% | 0 shares | 1.21M | $68.17 | 287.6K | |
| Q1 2021 | share | Increase | +49.64% | 95.4K shares | 7.39M | $63.33 | 287.6K |
| Q4 2020 | share | 0.00% | 0 shares | -947K | $56.43 | 192.2K | |
| Q3 2020 | share | 0.00% | 0 shares | -2.64M | $60.52 | 192.2K | |
| Q2 2020 | share | Decrease | -86.93% | -1.27M shares | -95.19M | $72.94 | 192.2K |
| Q1 2020 | share | Increase | +351.12% | 1.14M shares | 88.78M | $70.22 | 1.47M |
| Q4 2019 | share | 0.00% | 0 shares | 522K | $60.43 | 326.1K | |
| Q3 2019 | call | Decrease | -100.00% | -100K shares | -6.75M | $58.4 | 0 |
| Q3 2019 | share | Decrease | -18.80% | -75.5K shares | -6.46M | $58.4 | 326.1K |
| Q2 2019 | share | Decrease | -9.51% | -42.2K shares | -1.71M | $61.67 | 401.6K |
| Q2 2019 | call | Increase | 0.00% | 100K shares | 6.75M | $61.67 | 100K |
| Q1 2019 | share | 0.00% | 0 shares | 1.09M | $58.79 | 443.8K | |
| Q4 2018 | share | Increase | +21.72% | 79.2K shares | -391K | $56.02 | 443.8K |
| Q3 2018 | share | 0.00% | 0 shares | 2.32M | $68.57 | 364.6K | |
| Q2 2018 | share | 0.00% | 0 shares | -1.65M | $62.43 | 364.6K | |
| Q1 2018 | share | Decrease | -30.10% | -157K shares | -9.88M | $65.91 | 364.6K |
| Q4 2017 | share | Decrease | -72.95% | -1.40M shares | -118.84M | $62.19 | 521.6K |
| Q3 2017 | share | Decrease | -7.01% | -145.4K shares | 9.45M | $69.84 | 1.92M |
| Q2 2017 | share | Increase | +158.88% | 1.27M shares | 92.35M | $60.63 | 2.07M |
| Q1 2017 | share | Decrease | -24.09% | -254.2K shares | -21.15M | $57.72 | 800.9K |
| Q4 2016 | share | Decrease | -47.53% | -955.6K shares | -83.53M | $60.39 | 1.05M |
| Q3 2016 | share | Decrease | -34.57% | -1.06M shares | -97.25M | $66.31 | 2.01M |
| Q2 2016 | share | Increase | +1.78% | 53.7K shares | -21.00M | $69.49 | 3.07M |
| Q1 2016 | share | Decrease | -11.76% | -402.2K shares | -68.86M | $76.1 | 3.01M |